Skip to main content
. Author manuscript; available in PMC: 2020 Feb 9.
Published in final edited form as: Clin Cancer Res. 2017 Dec 7;24(5):1038–1047. doi: 10.1158/1078-0432.CCR-17-2289

Figure 3. Survival comparisons according to presence or absence of TP53 mutation.

Figure 3.

A. Comparison of survival among 60 subjects with sEGFR mutations with and without TP53 mutation.

B. Comparison of survival among 49 subjects with sEGFR mutations with a disruptive TP53 versus those without any TP53 mutation.

C. Comparison of survival among 83 subjects with sEGFR, ALKr, or ROS1r mutations with and without TP53 mutation.

D. Comparison of survival among 71 subjects with sEGFR, ALKr, or ROS1r mutations with a disruptive TP53 versus those without any TP53 mutation.